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Squamous cell carcinomas (SCCs) are 
the most frequent type of solid cancers 
affecting a broad range of tissues, such as 
skin, lung, oral cavity and genital tract, 
and, less frequently, bladder and thyroid. 
Their common feature is that they arise 
from stratified or pseudo-stratified epithe-
lia and are highly heterogeneous and often 
associated with a high degree of differen-
tiation, making them resilient to cancer 
therapy. One organ of choice to decipher 
the squamous differentiation program is 
the skin. In the basal layer of the epider-
mis, a dynamic equilibrium exists among 
populations with high self-renewal poten-
tial and cells at different stages of commit-
ment to differentiation. This equilibrium 
is essential for long-term tissue homeo-
stasis and prevention of carcinogenesis. 
Importantly, we previously showed that 
p53 activation in keratinocytes of the pro-
liferative compartment triggers a pro-dif-
ferentiation program, while its disruption 
accounts for the deranged differentiation 
program observed in keratinocyte-derived 
cancer cells. Notably, besides p53, only 
a few other driver genes are mutated in 
SCCs, pointing to the importance of epi-
genetics in this cancer type.
microRNAs (miRNAs) provide an 
important form of epigenetic control of 
gene expression frequently deranged in 
cancer. miRNAs are 17–25 nucleotide 
non-coding RNA molecules that mostly 
bind to the 3′ untranslated regions (UTR) 
of target mRNAs in a sequence specific 
manner in order to influence translation 
and/or transcript stability. They are often 
expressed in a lineage- and time-specific 
fashion and have the potential to control 
cell fate decisions.
In our recent work aimed at identifying 
miRNAs deregulated in cutaneous SCCs, 
we showed that levels of 2 specific miR-
NAs, miR-34a and miR-203, are consis-
tently reduced.1 While miR-203 has been 
intensively studied as a key inducer of 
keratinocyte differentiation limiting stem-
ness,2 the role of miR-34a in this process 
has been poorly explored. miR-34a is bet-
ter known as a mediator of p53 action on 
growth arrest, senescence, apoptosis, and 
epithelial–mesenchymal transition.3 miR-
34a maps to the 1p36 genomic region that 
is frequently deleted in human cancers, 
and its expression is downmodulated in a 
variety of cancers.
We found that miR-34a expression is 
induced with keratinocyte differentiation, 
and that its reduced expression in cutane-
ous SCCs can be explained by p53 loss 
of function as well as methylation of its 
promoter. miR-34a mediates the p53 pro-
differentiation effects in keratinocytes. 
Its increased expression, to levels similar 
to those found in differentiating kerati-
nocytes, is sufficient to induce important 
aspects of the differentiation program 
through a mechanism that can be uncou-
pled from induction of cell cycle arrest.
In search of miR-34a direct targets 
mediating its pro-differentiation function, 
we interrogated several genes downregu-
lated by miR-34a and harboring a miR-
34a binding sequence in their 3′UTR. 
Notch1, a transmembrane receptor 
known to have a positive role on kerati-
nocyte differentiation, fulfilled these cri-
teria, and its repression by miR-34a could 
not account for the pro-differentiation 
function of miR-34a. Instead, miR-34a 
participates in the fine-tuned regulation 
of Notch1 expression by p53. Another 
previously reported target of miR-34a is 
SIRT1, and an attractive hypothesis was 
that Sirtuins could mediate the miR-34a 
pro-differentiation function. Sirtuins are 
protein deacetylases and/or ADP-ribosyl 
transferases involved in a broad range of 
biological processes, like development/
differentiation, chromatin remodeling, 
metabolism, DNA repair and cell sur-
vival.4 SIRT1, a known miR-34a target in 
other cells, was only slightly regulated by 
miR-34a overoverexpression in keratino-
cytes. By contrast, SIRT6, the only other 
sirtuin family member that we found to 
have a miR-34a putative binding site in 
its 3′-UTR region, was downregulated by 
increased amounts of miR-34a. Silencing 
SIRT6 in primary keratinocytes and SCC 
cells could recapitulate at least partially 
the effects of miR-34a on differentiation, 
and SIRT6 overexpression counteracted 
the miR-34a pro-differentiation effects, 
making it a likely player in keratinocyte 
differentiation (Fig. 1). These findings are 
of possible clinical relevance, as opposed 
to miR-34a, we found that SIRT6 levels 
decrease during keratinocyte differen-
tiation, while SIRT6 is overexpressed in 
human precancerous lesions (actinic kera-
toses) as well as more advanced SCCs.1
SIRT6 plays a role in DNA repair, 
genomic stability, and glucose metabo-
lism4 and has been described as a tumor 
suppressor gene in hepatocellular and 
colorectal cancers.5,6 Our findings sug-
gest that SIRT6 could play an opposite 
and/or more complex function in kerati-
nocytes that needs further investigations. 
For instance, whether overexpression 
of SIRT6 promotes keratinocyte tumor 
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development has not yet been explored. 
Also, what are the mechanisms involved 
in the regulation of differentiation by 
SIRT6? Which functions of SIRT6 are 
required? While a possible tumor modula-
tory function of SIRT6 in skin and other 
tissues needs to be further investigated, a 
few recent reports have indicated that this 
protein is more expressed in tumor cell 
lines than corresponding normal cells. 
Notably, the negative correlation between 
SIRT6 and miR-34a expression that we 
have uncovered might apply to aging as 
well as to somatic cell reprogramming, 
which is restrained by miR-34a while 
enhanced by SIRT6.7,8 Given the targe-
table property of Sirtuins, the develop-
ment of SIRT6-specific inhibitors might 
be of therapeutic value for treatment 
of premalignant and malignant SCCs 
and beyond.
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Figure  1. mir-34a mediates p53 pro-differentiation effects with subsequent sirt6 silencing in 
keratinocytes. top: in normal epidermis, p53 activation promotes differentiation in cells of the pro-
liferative compartment through increased expression of mir-34a, which inhibits sirt6 expression. 
in sCCs, loss of p53 and mir-34a result in sirt6 protein accumulation and impaired differentia-
tion. Bottom: Mechanistically, upon differentiating signals, p53 activates transcriptionally mir-34a 
expression, which, in turn, inhibits sirt6 expression via direct binding to its 3'utr.
